Enfermedad tromboembólica venosa y cáncerUna asociación frecuente

  1. Julia Morán Sánchez
  2. Antonio Santisteban Espejo
Revista:
Actualidad médica

ISSN: 0365-7965

Any de publicació: 2019

Tom: 104

Número: 807

Pàgines: 128-130

Tipus: Article

DOI: 10.15568/AM.2019.807.AO01 DIALNET GOOGLE SCHOLAR lock_openDIGIBUG editor

Altres publicacions en: Actualidad médica

Resum

Vein thromboembolic disease constitutes a complex clinical entity and its appearance is increased in the population with a previous diagnosis of cancer. In this sense, the own biological actvity of cancer contributes to the development and dissemination of the thrombotic phenomena and, thus, leading to an increase in cancer-associated morbimortality. The aim of this study is to analyze the physiopathological basis, epidemiology, risk prediction models and to show a practical approach to the prophylaxis and treatment of this cancer complication. In this regard, this paper can contribute to the improvement in therapeutics and follow-up of these patients at hospital and primary care levels.

Referències bibliogràfiques

  • JB B, S. B. De l’Obliteration des veines et de son influence sur la formation des hydropisies partielles: consideration sur la hydropisies passive et general. Arch Gen Med. 1823;1:188–204.
  • Trousseau A. Phlegmasia alba dolens. Clin Med Hotel Paris. 1865;3:654–712.
  • Connolly GC, Francis CW. Cancer-associated thrombosis. Am Soc Hematol Educ Program [Internet]. 2013;2013(1):684– 91. Available from: https://www.ncbi.nlm.nih.gov/ pubmed/24319253
  • González Porras, JR. Páramo Fernández, J. A. Mateo Arranz J. Hemostasia y trombosis. Manual práctico. [Internet]. ARÁN EDICIONES, editor. Sociedad Española de Hematología y Hemoterapia; 2018. Available from: https://www.seth.es/index.php/component/content/article/66-publicaciones/1330-hemostasia-y-trombosis-manualpractico.html
  • Razak NBA, Jones G, Bhandari M, Berndt MC, Metharom P. Cancer-associated thrombosis: An overview of mechanisms, risk factors, and treatment. Cancers (Basel). 2018;10(10):1–21.
  • Ortega Soto I, Román álvarez MT. Hemostasia y Trombosis en la práctica clínica [Internet]. ERGON, editor. Sociedad Española de Hematología y Hemoterapia; 2018. Available from: https://www.seth.es/index.php/seth/la-sociedad/actividades-auspiciadas/2018/1283-hemostasia-ytrombosis-en-la-practica-clinica.html
  • Khorana AA, Kuderer NM, Culakova E, Lyman GH, Charles W. Francis. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood [Internet]. 2008;111(10):4902–8. Available from: http://www.bloodjournal.org/content/111/10/4902.long?ssochecked=true
  • Pachón V, Trujillo-Santos J, Domènech P, Gallardo E, Font C, González-Porras JR, et al. Cancer-Associated Thrombosis: Beyond Clinical Practice Guidelines—A Multidisciplinary (SEMI–SEOM–SETH) Expert Consensus. TH Open. 2018;02(04):e373–86.
  • SEOM. II Consenso sobre la Enfermedad Tromboembólica Venosa en pacientes con Cáncer [Internet]. 2014. 139 p. Available from: https://seom.org/seomcms/images/stories/recursos/II_Consenso_SEOM_enf_tromboembolica_cancer.pdf
  • Lee AYY, Peterson EA. Treatment of cancer-associated thrombosis. Blood. 2013;122(14):2310–7.
  • Lyman GH, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2013;31(17):2189–204.
  • Elyamany G, Alzahrani AM, Eman B. Cancer-Associated Thrombosis: An Overview. Clin Med Insights Oncol. 2014;8:129–37.
Fuente de los datos: Dialnet